TransMedics expanded its National OCS Program (NOP) to additional US states, enhancing nationwide logistics and transplant coordination for heart, lung, and liver transplants through its proprietary normothermic technology platform.
The global organ preservation market is projected to reach USD 0.3 billion by 2030, growing from USD 0.2 billion in 2025, at a CAGR of 6.8% during the forecast period. This growth is fueled by the rising demand for organ transplants, the increasing incidence of chronic diseases such as kidney failure, diabetes, and hypertension, and the growing number of road accidents and trauma cases worldwide. As the global gap between organ supply and demand widens, efficient and innovative preservation methods have become essential to improving transplant success rates and reducing organ wastage.
Organ preservation is a critical step in transplantation procedures, ensuring the viability and functionality of donor organs until they are transplanted into recipients. Innovations in preservation solutions, perfusion systems, and storage techniques are transforming the field, enhancing both the quality and longevity of preserved organs.
Download PDF Brochure
Key Growth Drivers
* Rising Incidence of Organ Failure and Chronic Diseases The global prevalence of chronic conditions such as end-stage renal disease (ESRD), liver cirrhosis, and heart failure is driving the need for organ transplantation. Lifestyle-related diseases like obesity, hypertension, and diabetes are leading causes of organ dysfunction, particularly kidney and liver failure. As patient populations expand, so does the requirement for high-performance preservation solutions that ensure organs remain viable during transportation and surgery preparation.
* Increasing Organ Donation Awareness and Transplant Activity The growing number of organ donors — supported by awareness campaigns and improved legal frameworks — has led to a surge in transplant procedures globally. Governments and non-profit organizations are actively promoting organ donation through educational initiatives and partnerships with healthcare systems. This rising transplantation activity directly boosts demand for organ preservation solutions and equipment that ensure optimal organ condition from retrieval to implantation.
* Technological Advancements in Preservation Methods The market is experiencing significant innovation, particularly in machine perfusion technologies such as hypothermic and normothermic perfusion systems. These advanced systems allow continuous oxygenation and nutrient delivery to organs, improving preservation duration and post-transplant outcomes compared to traditional static cold storage (SCS). Additionally, manufacturers are developing novel preservation solutions that reduce oxidative stress and tissue injury, helping extend the storage life of sensitive organs such as the heart and lungs.
* Government Initiatives and Healthcare Infrastructure Development Supportive policies, increased healthcare spending, and the expansion of specialized transplant centers in emerging economies are key market growth enablers. Governments in countries such as India, China, and Japan are implementing national organ donation programs and establishing robust organ sharing networks, ensuring better access to transplantation procedures and preservation technologies.
Market Segmentation Insights
By Solution Type: UW Solution Dominates Global Adoption
Based on solution type, the University of Wisconsin (UW) solution accounted for the largest market share in 2024. This solution has become the gold standard for organ preservation, especially for the liver, kidneys, and pancreas, due to its superior ability to minimize ischemic injury during storage.
The UW solution’s effectiveness lies in its unique composition, which includes lactobionate and raffinose — metabolically inactive compounds that help maintain osmotic balance, protect cellular integrity, and reduce tissue damage. Its proven efficacy in enhancing transplant outcomes and reducing post-transplant complications has solidified its position as the preferred choice among transplant centers worldwide.
Other widely used preservation solutions include Custodial HTK, known for its low viscosity and rapid organ cooling capabilities, and Perfadex, primarily used in lung preservation due to its ability to minimize edema formation and improve oxygenation.
By Technique: Static Cold Storage (SCS) Leads the Market
By technique, the static cold storage (SCS) segment is expected to dominate the global organ preservation market during the forecast period. SCS remains the most commonly used technique across transplant centers due to its simplicity, cost-effectiveness, and proven clinical reliability. It involves cooling the organ to hypothermic temperatures to slow down metabolic processes and minimize cellular damage.
While hypothermic and normothermic machine perfusion systems are gaining attention for their ability to extend preservation times and improve organ recovery post-transplant, SCS remains the preferred method, particularly for kidney and liver transplants. Ongoing improvements in cold storage solutions and transportation logistics are further supporting this technique’s continued use.
By Organ Type: Kidney Transplants Drive Market Demand
The kidney segment accounted for the largest share of the organ preservation market in 2024. The dominance of this segment is primarily attributed to the rising global prevalence of kidney failure and the increasing number of renal transplant procedures.
Kidney transplantation remains the most effective treatment for end-stage renal disease (ESRD), offering better survival outcomes and quality of life compared to long-term dialysis. As the number of patients requiring transplants continues to increase, demand for efficient preservation technologies to maintain organ viability is growing correspondingly.
By End User: Transplant Centers Hold the Largest Share
Based on end user, transplant centers held the largest market share in 2024. These centers serve as critical hubs for organ retrieval, preservation, and transplantation, utilizing advanced preservation solutions and technologies to ensure successful outcomes.
The establishment of dedicated transplant programs within hospitals and specialized institutions has further driven the adoption of high-quality preservation solutions. Moreover, the rising number of multi-organ transplant procedures and collaborative networks between hospitals and research institutions contribute to the segment’s continued dominance.
Regional Insights
Asia Pacific: Fastest-Growing Regional Market
The Asia Pacific region is projected to register the highest CAGR in the global organ preservation market during the forecast period. The region’s growth is fueled by rising public awareness of organ donation, government-backed healthcare reforms, and expanded access to transplantation services.
Countries like China, Japan, India, and South Korea are emerging as key players, with advancements in healthcare infrastructure, standardized organ donation systems, and growing medical tourism contributing to rapid market expansion. Additionally, the increasing prevalence of chronic diseases and organ failure across these nations underscores the need for effective preservation technologies.
Request Sample Report
North America and Europe: Established Market Leaders
North America currently dominates the global organ preservation market, supported by advanced healthcare infrastructure, strong transplant networks, and the presence of leading manufacturers such as Paragonix Technologies, TransMedics, and Essential Pharmaceuticals. Similarly, Europe holds a significant share due to established organ donation frameworks and the availability of cutting-edge preservation technologies, particularly in Germany, the UK, and France.
Competitive Landscape
The global organ preservation market is moderately consolidated, with key players focusing on technological innovation, strategic collaborations, and geographic expansion. Leading companies include:
* Paragonix Technologies (US)
* XVIVO Perfusion AB (Sweden)
* Dr. Franz Köhler Chemie GmbH (Germany)
* Essential Pharmaceuticals, LLC (US)
* TransMedics (US)
* OrganOx Limited (UK)
* Bridge to Life Limited (US)
* Shanghai Genext Medical Technology (China)
* Preservation Solutions (US)
* Institut Georges Lopez (France)
These companies are driving innovation through next-generation perfusion systems, extended organ preservation platforms, and portable transport technologies designed to enhance organ quality and survival rates.
Future Outlook
The future of the organ preservation market lies in machine-based preservation systems, AI-integrated monitoring technologies, and portable perfusion devices that enable real-time organ viability assessment during transport. As global organ donation rates rise and healthcare systems strengthen transplant capabilities, demand for advanced, cost-effective, and scalable preservation solutions will continue to grow.
With increasing awareness, policy support, and technological breakthroughs, the organ preservation market is positioned for steady expansion, ensuring improved outcomes for transplant patients worldwide.
News From
MarketsandMarkets™
Category: Industry Reports & Market Analysis Profile: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, w …
This email address is being protected from spambots. You need JavaScript enabled to view it.
